These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28483660)

  • 21. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
    Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
    Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.
    Vares EA; Lehmann S; Sauer C; Pariante C; Wieland F; Soltmann B; Bauer M; Ritter P
    J Affect Disord; 2020 Dec; 277():450-455. PubMed ID: 32871531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggression Protects Against the Onset of Major Depressive Episodes in Individuals With Bipolar Spectrum Disorder.
    Ng TH; Freed RD; Titone MK; Stange JP; Weiss RB; Abramson LY; Alloy LB
    Behav Ther; 2017 May; 48(3):311-321. PubMed ID: 28390495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Perlis RH; Ostacher MJ; Patel JK; Marangell LB; Zhang H; Wisniewski SR; Ketter TA; Miklowitz DJ; Otto MW; Gyulai L; Reilly-Harrington NA; Nierenberg AA; Sachs GS; Thase ME
    Am J Psychiatry; 2006 Feb; 163(2):217-24. PubMed ID: 16449474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
    Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
    Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.
    Mothapo KM; Ten Oever J; Koopmans P; Stelma FF; Burm S; Bajramovic J; Verbeek MM; Rikkert MGO; Netea MG; Koopman G; van der Ven AJ
    J Neurovirol; 2017 Apr; 23(2):250-259. PubMed ID: 27882497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
    Mañé-Martínez MA; Olsson B; Bau L; Matas E; Cobo-Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
    J Neuroimmunol; 2016 Oct; 299():112-117. PubMed ID: 27725108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls.
    Zhang R; Song J; Isgren A; Jakobsson J; Blennow K; Sellgren CM; Zetterberg H; Bergen SE; Landén M
    Transl Psychiatry; 2020 Feb; 10(1):58. PubMed ID: 32066700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder.
    Dodd S; Kulkarni J; Berk L; Ng F; Fitzgerald PB; de Castella AR; Filia S; Filia K; Montgomery W; Kelin K; Smith M; Brnabic A; Berk M
    J Affect Disord; 2010 Jul; 124(1-2):22-8. PubMed ID: 19944466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode.
    Li H; Hong W; Zhang C; Wu Z; Wang Z; Yuan C; Li Z; Huang J; Lin Z; Fang Y
    J Affect Disord; 2015 Mar; 174():361-6. PubMed ID: 25545602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study.
    Giné-Servén E; Martinez-Ramirez M; Boix-Quintana E; Davi-Loscos E; Guanyabens N; Casado V; Muriana D; Torres-Rivas C; Crespo-Facorro B; Labad J
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110424. PubMed ID: 34363867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
    Hermansson L; Yilmaz A; Axelsson M; Blennow K; Fuchs D; Hagberg L; Lycke J; Zetterberg H; Gisslén M
    J Neuroinflammation; 2019 Jan; 16(1):16. PubMed ID: 30678707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of bipolar I and II disorders by examining for differences in severity of manic/hypomanic symptoms and the presence or absence of psychosis during that phase.
    Parker G; Graham R; Hadzi-Pavlovic D; McCraw S; Hong M; Friend P
    J Affect Disord; 2013 Sep; 150(3):941-7. PubMed ID: 23774140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
    Deming Y; Black K; Carrell D; Cai Y; Del-Aguila JL; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Bertelsen S; Huang KL; Sutphen CL; Tarawneh R; Fagan AM; Holtzman DM; Morris JC; Goate AM; Dougherty JD; Cruchaga C
    BMC Neurol; 2016 Nov; 16(1):217. PubMed ID: 27832767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    Bettcher BM; Johnson SC; Fitch R; Casaletto KB; Heffernan KS; Asthana S; Zetterberg H; Blennow K; Carlsson CM; Neuhaus J; Bendlin BB; Kramer JH
    J Alzheimers Dis; 2018; 62(1):385-397. PubMed ID: 29439331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.